인사말
심근경색증, 협심증, 말초혈관질환, 고지혈증
| 구분 | 월 | 화 | 수 | 목 | 금 | 토 | |
|---|---|---|---|---|---|---|---|
| 노인센터 | 오전 |
|
|
||||
| 오후 |
|
||||||
| 응급센터 | 오전 |
|
|
||||
| 오후 |
|
|
|||||
-
특이사항이 없습니다.
-
전남대학교 의과대학 졸업
-
울산대학교 의학석사
-
전남대학교 의학박사
-
아산재단 서울중앙병원 심장내과 전임의
-
전북대학교 의과대학 심장내과임상교수, 전임강사, 조교수, 부교수
-
미국 오하이오 주립대학 연수
-
전북대학교 의과대학 심장내과 교수
-
건강보험심사평가원 진료심사평가위위회 전문위원
-
건강보험심사평가원 진료심사평가위위회 비상근심사위원
-
대한내과학회 정회원
-
대한심장학회 정회원
-
대한심혈관중재시술학회 정회원
-
심근경색증학회 정회원
-
한국지질동맥경화학회 정회원
-
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study. Chonnam Med J 2024;60:78-86.
View PubMed(상세보기) -
Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice. J Korean Med Sci 2023;38:e34.
View PubMed(상세보기) -
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial. Am Heart J 2023;259:58–67.
View PubMed(상세보기) -
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial. Am Heart J 2023;264:83–96.
View PubMed(상세보기) -
Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial. J Clin Med 2023;12:1-12.
View PubMed(상세보기) -
The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction. Korean J Intern Med 2022;37:350-65.
View PubMed(상세보기) -
Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study. J Clin Med 2022;11:1-12.
View PubMed(상세보기) -
Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction. MEDICINE 2022:101(42):1-12.
View PubMed(상세보기) -
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother 2021;7:112-24.
View PubMed(상세보기) -
Clinical Implication of ‘Obesity Paradox’ in Elderly Patients With Acute Myocardial Infarction. Heart Lung Circ 2021;30:481–8.
View PubMed(상세보기) -
Safety of 3-month dual antiplatelet therapy after implantation of ultrathin sirolimus-eluting stents with biodegradable polymer (Orsiro): Results from the SMART-CHOICE trial. J Am Heart Assoc 2021;10:1-9.
View PubMed(상세보기) -
Gender differences in clinical outcomes of acute myocardial infarction undergoing percutaneous coronary intervention: insights from the KAMIR-NIH Registry. J Geriatr Cardiol 2020;17: 680-93.
View PubMed(상세보기) -
Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia: A Randomized, Open-labeled, Multicentered, Phase IV Study. Clin Ther 2020;42:2036-48.
View PubMed(상세보기) -
Social defeat stress induces myocardial injury by modulating inflammatory factors. J Int Med Res 2020;48:200060520936903.
View PubMed(상세보기)